高血圧におけるプライマリ予防. 観察研究から得られた妥当な結論
A W Hoes1, D E Grobbee, J Lubsen
1Department of Epidemiology and Biostatistics, Erasmus University Medical School, Rotterdam, The Netherlands.
Circulation
|December 1, 1991
まとめ
冠動脈疾患の初次予防のための抗高血圧薬に関する観察研究は限られている. 入手可能なデータは,β阻害剤がより高い保護を提供することを示唆しているが,さらなる研究が必要である.
科学分野:
- 心臓病学 心臓病学
- 薬理学 薬理学とは
- エピデミオロジー エピデミオロジー
背景:
- 冠動脈性心疾患 (CHD) の初次予防のための抗高血圧薬療法に関する限られた観察研究は存在します.
- 内部的妥当性を確保し,特に指示による混同を回避することは,この分野における観察研究にとって極めて重要です.
研究 の 目的:
- 主要なCHD予防のための抗高血圧薬の有効性を評価する観察研究の役割と課題をレビューする.
- ランダム化試験と比較した観察デザインの潜在的な利点と限界を強調する.
主な方法:
- 抗高血圧療法と初次性心血管疾患予防に関する既存の観察研究 (フォローアップとケースコントロール) のレビュー.
- 非ランダム化研究における内部的妥当性および比較性を確保するための方法論的考察の議論.
主要な成果:
- このトピックに関する高品質の観察研究はほとんど発表されていません.
- 予備的な研究結果は,ベータブロッカーは,他の抗高血圧療法と比較して,最初のCHDイベントに対して優れた保護を提供することを示唆しています.
結論:
- 観察研究は,初次性心血管疾患の予防のための抗高血圧療法に貴重な洞察を寄与することができます.
- 観測デザインの固有の可能性と落とし穴を評価することは,この研究分野での効果的な使用の鍵です.
- ベータブロッカーのような特定の薬物クラスの潜在的な利点を確認するために,さらに強力な観察研究が必要である.
さらに関連する動画
関連する概念動画
01:28Factors affecting Blood pressure
Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
Physiological Factors:
01:25Errors occurring during blood pressure monitoring
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Several factors...
01:18Hypertension and Regulation of Blood Pressure
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...